Envisia Therapeutics Garners $10,117,521 Series A Funding
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=898cc41c-fa1f-4fe6-b784-4a83811dd261
Date 3/18/2016
Company Name Envisia Therapeutics
Mailing Address P.O. Box 110065 Research Triangle Park, NC 27709 USA
Company Description Envisia encourages applications from highly motivated individuals who excel in their field of expertise and enjoy a fast-paced, challenging work environment.
Proceeds Purposes Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal amount of $4,944,000. Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.